Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications.

O'Dell JR, Haire CE, Erikson N, Drymalski W, Palmer W, Eckhoff PJ, Garwood V, Maloley P, Klassen LW, Wees S, Klein H, Moore GF.

N Engl J Med. 1996 May 16;334(20):1287-91.

2.

Rational use of new and existing disease-modifying agents in rheumatoid arthritis.

Kremer JM.

Ann Intern Med. 2001 Apr 17;134(8):695-706. Review.

PMID:
11304108
3.

[The goal for the treatment of rheumatoid arthritis should be remission].

Möttönen T, Mäkinen H, Puolakka K.

Duodecim. 2010;126(12):1457-64. Review. Finnish.

PMID:
20617749
4.

Rheumatoid arthritis: choice of antirheumatic treatment. Methotrexate first.

[No authors listed]

Prescrire Int. 2010 Feb;19(105):30-4. Review.

PMID:
20455343
5.

The combination of methotrexate, sulfasalazine and hydroxychloroquine is highly effective in rheumatoid arthritis.

Furst DE.

Clin Exp Rheumatol. 1999 Jan-Feb;17(1):39-40. Review. No abstract available.

PMID:
10084027
6.

Combination of second-line antirheumatic drugs.

Haagsma CJ, van Riel PL.

Ann Med. 1997 Apr;29(2):169-73. Review.

PMID:
9187235
7.

Disease-modifying antirheumatic drugs.

Conaghan PG, Lehmann T, Brooks P.

Curr Opin Rheumatol. 1997 May;9(3):183-90. Review.

PMID:
9204252
8.

Disease-modifying antirheumatic drugs.

Ryan L, Brooks P.

Curr Opin Rheumatol. 1999 May;11(3):161-6. Review.

PMID:
10328573
9.

Medical therapy: where are we now?

Resman-Targoff BH.

Am J Health Syst Pharm. 2006 Sep 15;63(18 Suppl 4):S11-8. Review.

PMID:
16960243
10.

Advances in the medical management of rheumatoid arthritis.

Scott DL.

Hosp Med. 2002 May;63(5):294-7. Review.

PMID:
12066349
11.

[Combination therapy in rheumatoid arthritis].

Johnsen V, Førre Ø, Haga HJ, Kvien TK, Mikkelsen K, Nordvåg BY, Rødevand E.

Tidsskr Nor Laegeforen. 2003 May 29;123(11):1511-3. Review. Norwegian.

PMID:
12822010
12.

Combination sulfasalazine and methotrexate in the management of rheumatoid arthritis.

Shiroky JB.

J Rheumatol Suppl. 1996 Mar;44:69-71. Review.

PMID:
8833057
13.

Rheumatoid arthritis: new developments in the use of existing therapies.

O'Dell JR, Scott DL.

Rheumatology (Oxford). 1999 Nov;38 Suppl 2:24-6. Review.

PMID:
10646486
14.

Rheumatoid arthritis: more aggressive approach improves outlook.

Weinblatt ME.

Cleve Clin J Med. 2004 May;71(5):409-13. Review.

PMID:
15195775
15.

Disease-modifying antirheumatic drugs. Potential effects in older patients.

Gardner G, Furst DE.

Drugs Aging. 1995 Dec;7(6):420-37. Review.

PMID:
8601050
16.

Efficacy of triple association methotrexate, sulfasalazine and hydroxychloroquine in early treatment of rheumatoid arthritis with insufficient response to methotrexate: Meta-analysis of randomized controlled trials.

Mazouyès A, Clay M, Bernard AC, Gaudin P, Baillet A.

Joint Bone Spine. 2017 Oct;84(5):563-570. doi: 10.1016/j.jbspin.2016.10.010. Epub 2016 Dec 15. Review.

PMID:
27989589
17.

Combination therapy for rheumatoid arthritis: methotrexate and sulfasalazine together or with other DMARDs.

Dale J, Alcorn N, Capell H, Madhok R.

Nat Clin Pract Rheumatol. 2007 Aug;3(8):450-8; quiz, following 478. Review.

PMID:
17664952
18.

[Update on Current Care Guidelines. Rheumatoid Arthritis (RA)].

[No authors listed]

Duodecim. 2015;131(15):1409-10. Review. Finnish.

PMID:
26433976
19.

Aim for remission or "personal best" using combination DMARD therapy with methotrexate and hydroxychloroquine.

Bensen W, Bensen W.

Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S95-101. Review.

PMID:
10589366
20.

Disease-modifying antirheumatic drugs other than methotrexate in rheumatoid arthritis and seronegative arthritis.

Nandi P, Kingsley GH, Scott DL.

Curr Opin Rheumatol. 2008 May;20(3):251-6. doi: 10.1097/BOR.0b013e3282fb7caa. Review.

PMID:
18388514

Supplemental Content

Support Center